Los puntos clave no están disponibles para este artículo en este momento.
The new vancomycin dose prediction model is potentially useful for patients whose population profiles are similar to those of our patients and yielded desired reference of clinical indicators with specific breakpoints.
Huang et al. (Fri,) studied this question.